Robert J. De Vaere
2011
In 2011, Robert J. De Vaere earned a total compensation of $874K as Executive Vice President and Chief Financial Officer at Horizon Pharma.
Compensation breakdown
| Non-Equity Incentive Plan | $162,800 |
|---|---|
| Option Awards | $197,170 |
| Salary | $350,000 |
| Stock Awards | $162,843 |
| Other | $1,156 |
| Total | $873,969 |
De Vaere received $350K in salary, accounting for 40% of the total pay in 2011.
De Vaere also received $162.8K in non-equity incentive plan, $197.2K in option awards, $162.8K in stock awards and $1.2K in other compensation.
Rankings
In 2011, Robert J. De Vaere's compensation ranked 6,139th out of 10,747 executives tracked by ExecPay. In other words, De Vaere earned more than 42.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,139 out of 10,747 | 43rd |
Division Manufacturing | 2,225 out of 3,960 | 44th |
Major group Chemicals And Allied Products | 503 out of 1,033 | 51st |
Industry group Drugs | 329 out of 781 | 58th |
Industry Pharmaceutical Preparations | 263 out of 571 | 54th |
Source: SEC filing on June 2, 2014.
De Vaere's colleagues
We found four more compensation records of executives who worked with Robert J. De Vaere at Horizon Pharma in 2011.
2011
Timothy Walbert
Horizon Pharma
Chief Executive Officer
2011
Jeffrey Sherman
Horizon Pharma
Chief Medical Officer
2011
Michael Adatto
Horizon Pharma
Former Senior Vice President, Managed Care and Commercial Development
2011
Todd Smith
Horizon Pharma